MiNK Therapeutics
INKT----
Forecast & Rating2 analysts currently cover MiNK Therapeutics, of which 2 give a positive rating. The average price target is $42.50, about 290.3% upside from the current price of $10.89. Coverage is limited, so the data is for reference only. Data as of Oct 21, 2026; this does not constitute investment advice.
Oct 21, 2026Price forecast
$42.50290.27%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateOct 26, 2026
Forecast met12.4%
Stock price$10.89
Avg. target$39.0
High target$43
Low target$35
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.